Investing.com - Myovant Sciences (NYSE: MYOV) reported third quarter EPS of $-0.59, $0.14 worse than the analyst estimate of $-0.45. Revenue for the quarter came in at $100.23M versus the consensus estimate of $109.36M.
Myovant Sciences's stock price closed at $26.90. It is up 0% in the last 3 months and up 114.68% in the last 12 months.
Myovant Sciences saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Myovant Sciences's stock price’s past reactions to earnings here.
According to InvestingPro, Myovant Sciences's Financial Health score is "fair performance".
Check out Myovant Sciences's recent earnings performance, and Myovant Sciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar